Fifth Third Bancorp’s Onconetix ONCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1
Closed -$134 2739
2025
Q2
$134 Hold
1
﹤0.01% 2537
2025
Q1
$188 Hold
1
﹤0.01% 2503
2024
Q4
$1.51K Hold
1
﹤0.01% 2356
2024
Q3
$12.5K Hold
1
﹤0.01% 1921
2024
Q2
$16.1K Hold
1
﹤0.01% 1779
2024
Q1
$14.8K Hold
1
﹤0.01% 1753
2023
Q4
$19K Hold
1
﹤0.01% 1775
2023
Q3
$49.2K Hold
1
﹤0.01% 1359
2023
Q2
$109K Buy
+1
New +$174K ﹤0.01% 1123
2023
Q1
Hold
0
1578
2022
Q4
Hold
0
1455
2022
Q3
Hold
0
1641

Other funds holding ONCO

Fifth Third Bancorp's ONCO Position: Q3 2025 in Review

Fifth Third Bancorp sold out of Onconetix (ONCO) in Q3 2025, closing a stake of 1 share — an estimated $134 sold.

Fifth Third Bancorp first reported a position in ONCO in Q2 2023 and held it in 9 quarters. The position peaked at $109K in Q2 2023. 6 funds tracked by Wall St. Rank hold ONCO as of Q3 2025.

  • Fifth Third Bancorp reported no remaining Onconetix position as of Q3 2025 after selling out during the quarter.
  • Fifth Third Bancorp sold 1 Onconetix share in Q3 2025, an estimated $134.
  • Fifth Third Bancorp first reported a position in Onconetix in Q2 2023 and held it in 9 quarters.
  • Fifth Third Bancorp's Onconetix position peaked at $109K in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Onconetix as of Q3 2025.

Based on Fifth Third Bancorp's 13F filing for Q3 2025, filed 7 Nov 2025.